Andere Sprachen Akoya Biosciences, Inc.

Aktien

A3CM1B

US00974H1041

AKYA

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 07.05.2024			% 5 Tage	% 1. Jan.
4,08 ^USD	-0,97 %		+6,81 %	-16,39 %

06.05.	Akoya Biosciences eröffnet Operations- und Produktionszentrum in Marlborough, Massachusetts	CI
02.05.	Akoya Biosciences und Shanghai KR Pharmtech geben die Vorab-Zulassung der chinesischen Aufsichtsbehörde für KR-HT5 in China zur Unterstützung der klinischen Arbeitsabläufe in der Pathologie der nächsten Generation bekannt	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06.05.
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06.05.
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts	06.05.
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	02.05.
Akoya Biosciences and Shanghai KR Pharmtech Announces Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows	02.05.
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024	22.04.
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	05.04.
Akoya Biosciences Showcases Spatial Biology 2.0 Solutions At AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale	05.04.
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider	20.03.
Akoya Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024	04.03.
Akoya: Q4 Earnings Snapshot	04.03.
Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q4 Revenue $26.5M, vs. Street Est of $26.1M	04.03.
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	04.03.
Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook	04.03.
Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	04.03.
North American Morning Briefing : Stock Futures -2-	04.03.
Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference	08.02.
Akoya Biosciences Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	19.01.
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	18.01.
Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases	18.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Akoya Biosciences, Inc.

Aktien

A3CM1B

US00974H1041

AKYA

Andere Sprachen

Filter